Education
About Us
Working with TipRanks
Follow Us
Calyx Bio-Ventures Inc (TSE:CYX.H)
:CYX.H
Total Valuation
Calyx Bio-Ventures has a market cap or net worth of C$947.82K. The enterprise value is ―.
Market CapC$947.82K
Enterprise Value―
Share Statistics
Calyx Bio-Ventures has 94,781,654 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding94,781,654
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Calyx Bio-Ventures’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Calyx Bio-Ventures is ―. Calyx Bio-Ventures’s PEG ratio is ―.
PE Ratio―
PS Ratio9478.17
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Calyx Bio-Ventures had revenue of ― and earned -2.49M in profits. Earnings per share was ―.
Revenue―
Gross Profit2.40K
Operating Income-796.00K
Pretax Income―
Net Income-2.49M
EBITDA-1.62M
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Calyx Bio-Ventures pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average0.01
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Calyx Bio-Ventures upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Calyx Bio-Ventures as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Calyx Bio-Ventures has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Calyx Bio-Ventures EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Calyx Bio-Ventures has ― in cash and marketable securities with 0.00 in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt0.00
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Calyx Bio-Ventures is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―